Silent myocardial ischemia is associated with altered plasma phospholipids

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 1, 2009, Pages 45-50

  Lin, Hailong ^a   Zhang, Jing ^a   Gao, Peng ^b  

^a DALIAN MUNICIPAL CENTRAL HOSPITAL   (China)

^b DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Metabolomics; Myocardial ischemia; Phospholipids

Indexed keywords

1 LINOLEOYLGLYCEROPHOSPHOCHOLINE; 1 PALMITOYL LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLOMICS; PHOSPHOLIPID BLOOD LEVEL; SILENT MYOCARDIAL ISCHEMIA; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCARDIOGRAPHY; ENZYMES; EXERCISE TEST; FEMALE; HUMANS; LEAST-SQUARES ANALYSIS; MALE; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PHOSPHOLIPIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 58849084271     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20288     Document Type: Article

References (24)

1. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 2003;108:1263-1277.
2. Beishuizen ED, Jukema JW, Tamsma JT, et al. No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care 2005;28:1675-1679.
3. Cohn PF. Should silent ischemia be treated in asymptomatic individuals? Circulation 1990;82:II149-II154.
4. Erikssen J. Prognostic importance of silent ischemia during long-term follow-up of patients with coronary artery disease. A short review based on own experience and current literature. Herz 1987;12:359-368.
5. Weiner DA, Ryan TJ, McCabe CH, et al. Significance of silent myocardial ischemia during exercise testing in patients with coronary artery disease. Am J Cardiol 1987;59:725-729.
6. Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990;15:318-329.
7. He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 2000;101:244-251.
8. Lindon JC, Holmes E, Nicholson JK. Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 2004;6:265-272.
9. Clarke CJ, Haselden JN. Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol Pathol 2008;36:140-147.
10. Robert MM, Benoit JB, Lopez-Martinez G, Elnitsky MA, Lee Jr RE, Denlinger DL. Metabolomics reveals unique and shared metabolic changes in response to heat shock, freezing and desiccation in the Antarctic midge, Belgica antarctica. J Insect Physiol 2008.
11. Shyur LF, Yang NS. Metabolomics for phytomedicine research and drug development. Curr Opin Chem Biol 2008;12:66-71.
12. Brindle JT, Antti H, Holmes E, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002;8:1439-1444.
13. Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 2005;112:3868-3875.
14. Ferreira JF, Cesar LA, Gruppi CJ, et al. Silent myocardial ischemia in patients with stable coronary artery disease receiving conventional antianginal drug therapy. Arq Bras Cardiol 2007;89:283-288.
15. Robert MM, Benoit JB, Lopez-Martinez G, Elnitsky MA, Lee Jr RE, Denlinger DL. Metabolomics reveals unique and shared metabolic changes in response to heat shock, freezing and desiccation in the Antarctic midge, Belgica antarctica. J Insect Physiol 2008.
16. Shyur LF, Yang NS. Metabolomics for phytomedicine research and drug development. Curr Opin Chem Biol 2008;12:66-71.
17. Lindahl B, Venge P, Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes. Coron Artery Dis 1995;6:321-328.
18. Lindon JC, Nicholson JK, Holmes E, editors. The Handbook of Metabonomics and Metabolomics. Amsterdam: Elsevier BV, 2007.
19. Kume N, Cybulsky MI, Gimbrone Jr MA. Lysophosphatidylcho-line, a component of atherogenic lipoproteins, induces mono-nuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-1144.
20. Kume N, Gimbrone Jr MA. Lysophosphatidylcholine transcrip-tionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907-911.
21. Jing Q, Xin SM, Zhang WB, Wang P, Qin YW, Pei G. Lysopho-sphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res 2000;87:52-59.
22. Koh JS, Wang Z, Levine JS. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J Immunol 2000;165:4190-4201.
23. Choy PC, Chan M, Hatch G, Man RY. Phosphatidylcholine metabolism in ischemic and hypoxic hearts. Mol Cell Biochem 1992;116:53-58.
24. Bai Y, Wang J, Lu Y, Shan H, Yang B, Wang Z. Phospholipid lysophosphatidylcholine as a metabolic trigger and HERG as an ionic pathway for extracellular K accumulation and ''short QT syndrome'' in acute myocardial ischemia. Cell Physiol Biochem 2007;20:417-428.